Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for DYNTQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2025 -0.0003M
June 30, 2025 -0.0001M
March 31, 2025 -0.0192M
December 31, 2024 -0.0111M
September 30, 2024 0.00
June 30, 2024 -0.0023M
March 31, 2024 -0.0106M
December 31, 2023 -0.1958M
September 30, 2023 -0.0346M
June 30, 2023 -0.0098M
March 31, 2023 -0.0506M
December 31, 2022 -0.1067M
September 30, 2022 -0.0198M
June 30, 2022 -0.0565M
March 31, 2022 -0.163M
December 31, 2021 -0.0783M
September 30, 2021 -0.0201M
June 30, 2021 1.620M
March 31, 2021 -0.0171M
December 31, 2020 -0.0556M
September 30, 2020 -0.016M
June 30, 2020 -0.0427M
March 31, 2020 -0.0659M
December 31, 2019 -0.1178M
September 30, 2019 -0.066M
Date Value
June 30, 2019 -0.0993M
March 31, 2019 -0.0723M
December 31, 2018 -0.0264M
September 30, 2018 -0.0261M
June 30, 2018 -0.1119M
March 31, 2018 -0.0447M
December 31, 2017 -9.123M
September 30, 2017 -0.0139M
June 30, 2017 -9.070M
March 31, 2017 -0.1274M
December 31, 2016 -0.0109M
September 30, 2016 0.0061M
June 30, 2016 -0.1518M
March 31, 2016 -0.0236M
December 31, 2015 -0.0079M
September 30, 2015 -0.0126M
June 30, 2015 -0.0172M
March 31, 2015 -0.0295M
December 31, 2014 -0.0021M
September 30, 2014 3.782M
June 30, 2014 -0.0613M
March 31, 2014 -0.0702M
December 31, 2013 -0.0208M
September 30, 2013 -0.0247M
June 30, 2013 -0.0194M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Accuray, Inc. -1.353M
Micron Solutions, Inc. --
Orthofix Medical, Inc. -12.57M
ResMed, Inc. -383.65M
Rockwell Medical, Inc. -0.487M

Cash from Investing (Quarterly) Related Metrics